The following is a summary of “Dupilumab Improves Dermatology-Specific Quality of Life in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1 Antihistamines,” published in the February 2024 issue of Journal of Allergy and Clinical Immunology by Maurer et al. Chronic spontaneous urticaria (CSU) causes recurring wheals or angioedema for over 6 weeks. It significantly […]
The post Dupilumab Boosts Quality of Life in Patients With Chronic Spontaneous Urticaria first appeared on Physician’s Weekly.
